| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.442 | 30.160 | 53.547 | 65.195 | 40.676 | 19.010 | 25.758 | 28.887 | 34.172 | 20.145 |
| Total Income - EUR | 19.443 | 30.160 | 53.879 | 65.624 | 42.313 | 21.036 | 28.610 | 30.843 | 34.220 | 20.145 |
| Total Expenses - EUR | 16.013 | 17.380 | 16.181 | 16.779 | 19.204 | 12.244 | 9.465 | 10.173 | 14.941 | 13.535 |
| Gross Profit/Loss - EUR | 3.430 | 12.780 | 37.698 | 48.845 | 23.109 | 8.792 | 19.145 | 20.670 | 19.279 | 6.610 |
| Net Profit/Loss - EUR | 2.847 | 12.176 | 36.534 | 48.193 | 22.685 | 8.379 | 18.217 | 19.740 | 18.919 | 6.133 |
| Employees | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Alcor Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 626 | 375 | 13 | 0 | 0 | 0 | 0 | 1.798 | 1.307 | 1.179 |
| Current Assets | 5.793 | 12.636 | 36.827 | 47.645 | 44.362 | 43.938 | 45.811 | 48.816 | 51.739 | 43.803 |
| Inventories | 0 | 223 | 518 | 279 | 0 | 393 | 0 | 0 | 0 | 474 |
| Receivables | 2.283 | 2.851 | 14.652 | 5.936 | 5.441 | 1.519 | 2.098 | 1.420 | 2.913 | 439 |
| Cash | 3.510 | 9.562 | 21.657 | 41.429 | 38.921 | 42.026 | 43.713 | 47.396 | 48.826 | 42.890 |
| Shareholders Funds | 3.600 | 4.175 | 5.932 | 8.596 | 9.483 | 9.717 | 10.411 | 11.356 | 12.231 | 18.295 |
| Social Capital | 2.250 | 2.227 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | 2.820 | 8.835 | 30.907 | 39.049 | 34.879 | 34.221 | 35.400 | 39.259 | 40.816 | 26.687 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alcor Med Srl